|
rdf:type |
|
|
lifeskim:mentions |
|
|
pubmed:issue |
7
|
|
pubmed:dateCreated |
2006-7-25
|
|
pubmed:abstractText |
Blood pressure, which generally increases after menopause, is one of the best tools to characterize cardiovascular disease. The renin-aldosterone system plays a role in determining cardiovascular risk and the role of estrogen in the regulation of angiotensinogen gene expression and serum levels is well known. Raloxifene can induce endothelium-dependent vasodilation without affecting endothelium-independent vasorelaxation. The aim of the study was to investigate the effects of raloxifene on the renin-aldosterone system and blood pressure in postmenopausal women.
|
|
pubmed:language |
eng
|
|
pubmed:journal |
|
|
pubmed:citationSubset |
IM
|
|
pubmed:chemical |
|
|
pubmed:status |
MEDLINE
|
|
pubmed:month |
Jul
|
|
pubmed:issn |
0951-3590
|
|
pubmed:author |
|
|
pubmed:issnType |
Print
|
|
pubmed:volume |
22
|
|
pubmed:owner |
NLM
|
|
pubmed:authorsComplete |
Y
|
|
pubmed:pagination |
376-80
|
|
pubmed:meshHeading |
pubmed-meshheading:16864147-Aldosterone,
pubmed-meshheading:16864147-Antihypertensive Agents,
pubmed-meshheading:16864147-Blood Pressure,
pubmed-meshheading:16864147-Bone Density,
pubmed-meshheading:16864147-Female,
pubmed-meshheading:16864147-Humans,
pubmed-meshheading:16864147-Middle Aged,
pubmed-meshheading:16864147-Osteoporosis, Postmenopausal,
pubmed-meshheading:16864147-Postmenopause,
pubmed-meshheading:16864147-Raloxifene,
pubmed-meshheading:16864147-Renin,
pubmed-meshheading:16864147-Selective Estrogen Receptor Modulators
|
|
pubmed:year |
2006
|
|
pubmed:articleTitle |
Effects of raloxifene therapy on plasma renin and aldosterone levels and blood pressure in postmenopausal women.
|
|
pubmed:affiliation |
Department of Pediatrics, Obstetrics and Reproductive Medicine, Section of Obstetrics and Gynecology, University of Siena, Siena, Italy.
|
|
pubmed:publicationType |
Journal Article,
Controlled Clinical Trial
|
